The Venture Codex Logo

The Venture Codex

Ballad Ventures

303 MED TECH PARKWAY, SUITE 300, JOHNSON CITY, TN, 37604, UNITED STATES

Overview

Ballad Ventures is a venture capital platform focused on investing in innovative ideas which transform the health care experience, cost, access, and outcomes.

Total investments
3
Lead investments
0
Investments · 12mo
0
Active investors
0
Visit website

Investment portfolio

  • TailorMed

    Participated · Equity · Nov 2024

    TailorMed provides an enterprise platform that manages the full lifecycle of patient support programs to reduce cost barriers and improve medication access and adherence. The company has built the nation’s largest Affordability Network, deployed across more than 800 hospitals, 1,300 clinics, and 650 pharmacies. TailorMed integrates directly with manufacturer assistance programs to automate patient support and streamline stakeholder workflows. Having reached an inflection point in its network evolution, the company is expanding into an end-to-end platform to tackle cost, access, and adherence across the medication continuum. The new financing will fund that expansion and broader efforts to create a seamless flow of data and resources across patients, providers, pharmacies, life sciences, and payers. TailorMed frames this work as addressing affordability at the point a prescription is written or dispensed to prevent delayed or skipped treatments. TailorMed Medical provides a technology platform that automates identification of financially at-risk patients and matches and enrolls them in financial resources such as co-pay assistance, replacement drug programs, government subsidies, community and state resources, disease-specific foundations, and programs addressing living expenses. Its platform is designed to reduce out-of-pocket responsibility for patients, helping to eliminate downstream financial hardship and avoidance of care. For health organizations, TailorMed shifts financial assistance from reactive matching or downstream collections to a proactive, point-of-care approach. The company serves physician practices, specialty clinics and health systems, and in 2021 expanded adoption into pharmacies nationwide. TailorMed said it will use the new funding to further expand its reach across health care with innovative financial solutions. Srulik Dvorsky is CEO and co-founder and the company is based in New York City.

  • Homecare Hub

    Participated · Seed · Sep 2023

    Homecare Hub is a Toronto-based company building an on-demand, tech-enabled small care home platform to deliver home care and housing solutions. The company’s core product combines technology and on-demand services to support small care homes. It raised USD2.5M in seed funding and intends to use the funds to scale its solution. Backers included Froedtert Health’s venture arm Inception Health, Ballad Health’s venture arm Ballad Ventures, the Center for Aging + Brain Health Innovation (CABHI), AARP, Blue Lion Global, FHS Capital, and prominent angel investors. The round was announced alongside the company’s plans to expand its offering. Homecare Hub is led by CEO and Co-founder Dr. Vipan Nikore and technology leader Rahim Lalani. Dr. Nikore has clinical experience at the Cleveland Clinic and medical leadership roles, and Mr. Lalani has over 20 years of technology experience.

  • Censinet

    Participated · Equity · Jan 2023

    Censinet offers Censinet RiskOps, a cloud-based, HIPAA-secure risk exchange that automates third-party and enterprise risk-management workflows for providers, payers, and vendors. Its platform includes a Digital Risk Catalog of over 34,000 vendors and products, automated corrective action plans, real-time portfolio management, and Board-ready reporting. The company reports close to 40 customers, 100% ARR growth year-over-year through Q3 2022, and says it has never lost a customer. Censinet recently launched a Healthcare Cybersecurity Benchmarking Study co-sponsored by the American Hospital Association and KLAS Research. The new funding is earmarked for sales and marketing, product development, and customer success to expand the customer base, drive ACV expansion via new product modules, and enter adjacent markets and verticals. Censinet is based in Boston, MA. Censinet offers the Censinet Platform, described as the first third-party risk management platform built by and for healthcare providers to manage vendor threats to patient care. The platform includes One-click Assessment capabilities and a Digital Vendor Catalog that the company says reduce vendor risk assessment time from weeks to seconds, automate workflows, and provide continuous real-time vendor risk insights. Censinet maintains an advisory board of C-level executives from top-tier healthcare providers and vendors who served as design partners during product development. The company announced the launch of the Censinet Platform in April 2019 and emphasizes a security-first approach targeted at healthcare CIOs and CISOs. Censinet intends to use recent funding to expand the platform’s vendor risk management capabilities, scale its go-to-market team, and accelerate adoption by healthcare providers and their vendors. Censinet is led by CEO and Founder Ed Gaudet and is based in Boston, MA.

Team

No current team members are available.